Extendicare Historical Financial Ratios
| EXE Stock | CAD 10.38 0.04 0.39% |
Extendicare is recently reporting on over 96 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 7.29 or Days Sales Outstanding of 37.0 will help investors to properly organize and evaluate Extendicare financial condition quickly.
Extendicare |
About Extendicare Financial Ratios Analysis
ExtendicareFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Extendicare investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Extendicare financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Extendicare history.
Extendicare Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Extendicare stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Extendicare sales, a figure that is much harder to manipulate than other Extendicare multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Extendicare. There are two different methods for calculating Extendicare invested capital: operating approach and financing approach. Understanding Extendicare invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Intangibles To Total Assets
The ratio of a company's intangible assets (like goodwill and patents) to its total assets.Most ratios from Extendicare's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Extendicare current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Extendicare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Extendicare's EV To Sales is very stable compared to the past year. As of the 24th of November 2024, ROIC is likely to grow to 0.23, while Price To Sales Ratio is likely to drop 0.43.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0654 | 0.0729 | 0.0663 | 0.0746 | Price To Sales Ratio | 0.54 | 0.48 | 0.47 | 0.43 |
Extendicare fundamentals Correlations
Click cells to compare fundamentals
Extendicare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Extendicare fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 0.66 | 0.51 | 0.54 | 0.48 | 0.47 | 0.43 | |
| Dividend Yield | 0.0495 | 0.0692 | 0.0654 | 0.0729 | 0.0663 | 0.0746 | |
| Ptb Ratio | 6.52 | 4.65 | 6.45 | 5.8 | 6.94 | 7.29 | |
| Days Sales Outstanding | 21.39 | 23.13 | 25.06 | 19.14 | 25.46 | 37.0 | |
| Book Value Per Share | 1.28 | 1.29 | 1.43 | 1.13 | 1.03 | 0.98 | |
| Free Cash Flow Yield | (0.0178) | 0.016 | 0.15 | (0.009284) | (0.004992) | (0.17) | |
| Operating Cash Flow Per Share | 0.51 | 1.35 | 0.7 | 1.11 | 0.27 | 0.26 | |
| Stock Based Compensation To Revenue | 0.001412 | 0.001728 | 0.002931 | 0.002161 | 0.003218 | 0.003379 | |
| Pb Ratio | 6.52 | 4.65 | 6.45 | 5.8 | 6.94 | 7.29 | |
| Ev To Sales | 1.07 | 0.85 | 0.9 | 0.66 | 0.67 | 1.08 | |
| Free Cash Flow Per Share | 0.13 | 0.98 | (0.0678) | (0.0327) | (1.25) | (1.19) | |
| Roic | 0.0549 | 0.0974 | 0.0498 | 0.0434 | 0.22 | 0.23 | |
| Inventory Turnover | 425.35 | 382.86 | 103.51 | 423.82 | 381.44 | 400.51 | |
| Net Income Per Share | 0.32 | 0.19 | 0.47 | 0.1 | (0.0507) | 0.25 | |
| Days Of Inventory On Hand | 0.82 | 0.86 | 0.95 | 3.53 | 0.99 | 0.94 | |
| Payables Turnover | 7.64 | 7.9 | 5.72 | 5.63 | 4.73 | 6.02 | |
| Sales General And Administrative To Revenue | 0.0374 | 0.0423 | 0.94 | 0.95 | 0.0428 | 0.0406 | |
| Capex To Revenue | 0.0293 | 0.0286 | 0.0571 | 0.0832 | 0.0992 | 0.1 | |
| Cash Per Share | 1.06 | 2.0 | 1.16 | 1.88 | 0.89 | 0.91 | |
| Pocfratio | 16.65 | 4.92 | 10.36 | 5.92 | 26.21 | 27.52 | |
| Interest Coverage | 1.82 | 3.28 | 2.08 | 1.02 | 5.17 | 5.43 | |
| Payout Ratio | 2.18 | 0.97 | 4.77 | (9.43) | 1.19 | 1.97 | |
| Capex To Operating Cash Flow | 0.73 | 0.27 | 1.1 | 1.03 | 5.56 | 5.84 | |
| Pfcf Ratio | 62.66 | 6.76 | (107.71) | (200.31) | (5.75) | (5.46) | |
| Days Payables Outstanding | 46.2 | 63.85 | 64.8 | 77.23 | 60.63 | 63.66 | |
| Income Quality | 1.58 | 2.24 | 5.51 | 1.42 | 0.69 | 0.65 | |
| Roe | 0.15 | 0.33 | 0.0884 | (0.0448) | 0.39 | 0.3 | |
| Ev To Operating Cash Flow | 26.82 | 8.09 | 17.17 | 8.11 | 37.31 | 39.18 | |
| Pe Ratio | 44.13 | 14.0 | 72.89 | (129.44) | 17.96 | 18.92 | |
| Return On Tangible Assets | 0.0213 | 0.0487 | 0.0112 | (0.00659) | 0.062 | 0.0651 | |
| Ev To Free Cash Flow | 100.92 | 11.13 | (178.58) | (274.65) | (8.19) | (7.78) | |
| Earnings Yield | 0.0506 | 0.0227 | 0.0714 | 0.0137 | (0.007726) | 0.0283 | |
| Net Debt To E B I T D A | 5.08 | 3.08 | 6.41 | 4.43 | 2.62 | 3.86 | |
| Current Ratio | 0.69 | 0.67 | 1.06 | 0.8 | 0.94 | 0.83 | |
| Tangible Book Value Per Share | 0.29 | 0.45 | 0.1 | 0.0409 | (0.43) | (0.41) | |
| Receivables Turnover | 17.06 | 15.78 | 14.57 | 19.07 | 14.34 | 9.98 | |
| Graham Number | 2.36 | 3.9 | 1.6 | 1.14 | 3.05 | 6.05 | |
| Shareholders Equity Per Share | 1.28 | 1.29 | 1.43 | 1.13 | 1.03 | 0.98 |
Pair Trading with Extendicare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Extendicare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extendicare will appreciate offsetting losses from the drop in the long position's value.Moving together with Extendicare Stock
Moving against Extendicare Stock
The ability to find closely correlated positions to Extendicare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Extendicare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Extendicare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Extendicare to buy it.
The correlation of Extendicare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Extendicare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Extendicare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Extendicare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Extendicare Stock
ExtendicareFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Extendicare investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Extendicare financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Extendicare history.